Skip to main content
ScinoPharm Taiwan, Ltd. logo

ScinoPharm Taiwan, Ltd. — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,188 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country TW Taiwan
Listing TW 1789

About ScinoPharm Taiwan, Ltd.

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings
2026-05-06 Chinese
115年04月董事會成員及持股
Regulatory Filings
2026-05-06 Chinese
公告本公司法人董事改派代表人
Regulatory Filings
2026-04-30 Chinese
公告本公司115年第一季合併財務報告董事會預計召開日期 為115年05月06日
Report Publication Announcement Classification · 85% confidence The document is a short notice from the listed company announcing the board meeting date to consider and approve the Q1 consolidated financial report. It contains no actual financial data, only scheduling information for report approval. This is not the report itself but an announcement regarding the timing of a company report, matching the criteria for a Report Publication Announcement (RPA).
2026-04-28 Chinese
115年04月僑外投資持股
Regulatory Filings Classification · 75% confidence The document is a Chinese-language foreign and mainland China investor shareholding summary table (“僑外及大陸地區投資人投資持股情形統計表”) filed on the Market Observation Post System. It is a periodic disclosure of aggregate foreign shareholdings required by the regulator, not an earnings, dividend, or capital change announcement, nor a management discussion or AGM material. It does not report a major shareholding threshold crossing by an individual, but rather a routine regulatory shareholding report. Therefore, it falls under the general Regulatory Filings (RNS) fallback category.
2026-04-28 Chinese
115年年報及股東會資料 — 2026_1789_20260527F13.pdf
AGM Information Classification · 90% confidence The document is the “股東常會各項議案參考資料” (reference materials for the Annual General Meeting agenda) of Taiwan Shinlong Co., Ltd. It contains the prior year’s business report, audited financial statements, profit distribution proposal, amendments to the Articles and internal procedures, and other proposals for shareholder approval at the AGM. It is not a standalone annual report or earnings release but rather the materials prepared and shared for the Annual General Meeting. This matches AGM Information (Code: AGM-R).
2026-04-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.